Bruce Corser

1.2k total citations
23 papers, 591 citations indexed

About

Bruce Corser is a scholar working on Cognitive Neuroscience, Endocrine and Autonomic Systems and Experimental and Cognitive Psychology. According to data from OpenAlex, Bruce Corser has authored 23 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cognitive Neuroscience, 10 papers in Endocrine and Autonomic Systems and 10 papers in Experimental and Cognitive Psychology. Recurrent topics in Bruce Corser's work include Sleep and Wakefulness Research (15 papers), Sleep and related disorders (10 papers) and Circadian rhythm and melatonin (6 papers). Bruce Corser is often cited by papers focused on Sleep and Wakefulness Research (15 papers), Sleep and related disorders (10 papers) and Circadian rhythm and melatonin (6 papers). Bruce Corser collaborates with scholars based in United States, Canada and France. Bruce Corser's co-authors include David Seiden, Robert P. Baughman, Yves Dauvilliers, Alan Lankford, Karen L. Gunther, Steven Hull, Elyse E. Lower, Thomas Röth, Howard Schwartz and G. Turner and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Annals of Neurology.

In The Last Decade

Bruce Corser

22 papers receiving 563 citations

Peers

Bruce Corser
D. Alan Lankford United States
David V. Berkowitz United States
Nancy Kerner United States
Tom Rico United States
R Hajduković United States
David Winslow United States
D. Alan Lankford United States
Bruce Corser
Citations per year, relative to Bruce Corser Bruce Corser (= 1×) peers D. Alan Lankford

Countries citing papers authored by Bruce Corser

Since Specialization
Citations

This map shows the geographic impact of Bruce Corser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Corser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Corser more than expected).

Fields of papers citing papers by Bruce Corser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Corser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Corser. The network helps show where Bruce Corser may publish in the future.

Co-authorship network of co-authors of Bruce Corser

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Corser. A scholar is included among the top collaborators of Bruce Corser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Corser. Bruce Corser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corser, Bruce, et al.. (2024). RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates. SHILAP Revista de lepidopterología. 8. 100122–100122. 3 indexed citations
2.
Thorpy, Michael J., et al.. (2024). Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial. SHILAP Revista de lepidopterología. 7. 100109–100109. 1 indexed citations
4.
Corser, Bruce, Richard Bogan, Jennifer C. Franco, et al.. (2023). 0585 A four-week randomized, double-blind, placebo-controlled, phase 2 study of mazindol ER in the treatment of narcolepsy. SLEEP. 46(Supplement_1). A257–A257. 2 indexed citations
5.
Corser, Bruce, et al.. (2023). Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway. Journal of Clinical Sleep Medicine. 19(6). 1035–1042. 14 indexed citations
6.
Schweitzer, Paula K., Luigi Taranto‐Montemurro, Joseph Ojile, et al.. (2023). The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 208(12). 1316–1327. 41 indexed citations
7.
Bogan, Richard, Bruce Corser, Jennifer C. Franco, et al.. (2023). 0578 Clinician and Patient Global Impression in a Phase 2 Study of Mazindol (NLS-1021) in Adults with Narcolepsy Type 1 and Type 2. SLEEP. 46(Supplement_1). A254–A254. 1 indexed citations
8.
Ojile, Joseph, Paula K. Schweitzer, Stephen Thein, et al.. (2023). 0538 Mariposa: Oral Therapy AD109 Improves Objective & Patient Reported Outcomes In OSA. Randomized, Placebo Controlled Clinical Trial. SLEEP. 46(Supplement_1). A237–A237. 2 indexed citations
9.
Roth, Thomas, Yves Dauvilliers, Michael J. Thorpy, et al.. (2022). Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial. CNS Drugs. 36(4). 377–387. 20 indexed citations
10.
Dubow, Jordan, et al.. (2022). Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy. Patient Preference and Adherence. Volume 16. 937–947. 5 indexed citations
11.
Kushida, Clete A., Colin M. Shapiro, Thomas Roth, et al.. (2021). Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy. SLEEP. 45(6). 35 indexed citations
12.
Thorpy, Michael J., Colin M. Shapiro, Geert Mayer, et al.. (2019). A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Annals of Neurology. 85(3). 359–370. 110 indexed citations
13.
Lankford, D. Alan, Bruce Corser, Yanping Zheng, et al.. (2008). Effect of Gaboxadol on Sleep in Adult and Elderly Patients with Primary Insomnia: Results From Two Randomized, Placebo-Controlled, 30-Night Polysomnography Studies. SLEEP. 31(10). 1359–70. 32 indexed citations
14.
Burch, Francis X., et al.. (2007). A Comparison of the Analgesic Efficacy of Tramadol Contramid OAD Versus Placebo in Patients with Pain Due to Osteoarthritis. Journal of Pain and Symptom Management. 34(3). 328–338. 46 indexed citations
15.
Roth, Thomas, David Mayleben, Bruce Corser, & Nikhilesh Singh. (2007). Daytime pharmacodynamic and pharmacokinetic evaluation of low‐dose sublingual transmucosal zolpidem hemitartrate. Human Psychopharmacology Clinical and Experimental. 23(1). 13–20. 20 indexed citations
16.
Röth, Thomas, Steven Hull, Howard Schwartz, et al.. (2007). Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia. SLEEP. 30(11). 1555–1561. 111 indexed citations
17.
Zammit, Gary, Bruce Corser, Karl Doghramji, et al.. (2006). Sleep and Residual Sedation After Administration of Zaleplon, Zolpidem, and Placebo During Experimental Middle-of-the-Night Awakening. Journal of Clinical Sleep Medicine. 2(4). 417–423. 33 indexed citations
18.
Turner, G., Elyse E. Lower, Bruce Corser, Karen L. Gunther, & Robert P. Baughman. (1997). Sleep apnea in sarcoidosis.. PubMed. 14(1). 61–4. 68 indexed citations
19.
Javaheri, Shahrokh, et al.. (1992). Familial Respiratory Chemosensitivity Does Not Predict Hypercapnia of Patients with Sleep Apnea-Hypopnea Syndrome. American Review of Respiratory Disease. 145(4_pt_1). 837–840. 27 indexed citations
20.
Javaheri, Shahrokh, et al.. (1989). Diaphragmatic paralysis. The American Journal of Medicine. 86(5). 623–624. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026